Tyra Biosciences to Present at the 2024 Cantor Global Healthcare Conference
Express News | Tyra Biosciences Appoints Doug Warner, M.d., as Chief Medical Officer
Press Release: Tyra Biosciences Appoints Doug Warner, M.D., as Chief Medical Officer
Wall Street Analysts Think Tyra Biosciences (TYRA) Could Surge 27.88%: Read This Before Placing a Bet
Companies Like Tyra Biosciences (NASDAQ:TYRA) Are In A Position To Invest In Growth
Tyra Biosciences, Inc. (TYRA): One of Oppenheimer's Top Stock Picks For the Next 12 Months
Oppenheimer's Top 32 Ideas for August-September
Tyra Biosciences a New Overweight at Piper Sandler as 'Next Gen FGFR Company'
Piper Sandler Initiates TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Announces Target Price $33
Piper Sandler analyst Christopher Raymond initiates coverage on $TYRA BIOSCIENCES, INC.(TYRA.US)$ with a buy rating, and sets the target price at $33.According to TipRanks data, the analyst has a
Buy Rating for Tyra Biosciences Backed by TYRA-300's Potential and FGFR Expertise
Express News | Tyra Biosciences Inc : Piper Sandler Initiates Coverage With Overweight Rating; Target Price $33
Express News | Tyra Biosciences Inc. : Oppenheimer Cuts Target Price to $25 From $28
TYRA BIOSCIENCES, INC. | 10-Q: Q2 2024 Earnings Report
Express News | Tyra Biosciences Q2 Operating Income USD -23.532 Million Vs. IBES Estimate USD -24.9 Million
Express News | Tyra Biosciences Reports Second Quarter 2024 Financial Results and Highlights
Express News | Tyra Biosciences Q2 Net Income USD -18.702 Million
Press Release: Tyra Biosciences Reports Second Quarter 2024 Financial Results and Highlights
Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday
Calculating The Fair Value Of Tyra Biosciences, Inc. (NASDAQ:TYRA)
Oppenheimer Reiterates Outperform on Tyra Biosciences, Maintains $28 Price Target